Microbiology and Biotechnology Letters (한국미생물·생명공학회지)

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Synergistic Antibacterial Activity of Fig (Ficus carica) Leaves Extract Against Clinical Isolates of Methicillin-resistant Staphylococcus aureus

병원내에서 분리된 메티실린내성 황색포도상구균에 대한 무화과잎 추출물의 항미생물효과

  • Lee, Young-Soo (Department of Dental Hygiene, Sunmoon University) ;
  • Cha, Jeong-Dan (Department of Dental Hygiene, College of Natural Sciences, Dongeui University)
  • Received : 2010.06.29
  • Accepted : 2010.10.05
  • Published : 2010.12.28
Download PDF
⟨ Previous Next ⟩

Abstract

Fig (Ficus carica L.) belongs to the mulberry tree (Moraceae) which is one of the oldest fruits in the world. It has been used as a digestion promoter and a cure for ulcerative inflammation and eruption in Korea. The present study investigated the antimicrobial activity of methanol (MeOH) extract of fig leaves against methicillin-resistant Staphylococcus aureus (MRSA) isolated in clinic. The MeOH extract (MICs, 2.5 to 20 mg/mL; MBCs, 5 to 20 mg/mL) was demonstrated as antibacterial activity in isolates MRSA 1-20. The administration of the MeOH extract in combination with oxacillin or ampicillin induced a reduction of ${\geq}$4-8-fold in all tested bacteria, which was considered to be synergistic based on a FICI of ${\leq}$0.375-0.5. Furthermore, time-kill study was found that a combination of MeOH extract with oxacillin or ampicillin produced a more rapid decrease in the concentration of bacteria CFU/mL than MeOH extract alone. The results suggest that fig leaves could be employed as a natural antibacterial agent in MRSA infection care products.

무화과는 뽕나무 과에 속하며 세계에서 가장 오래된 과일 중 하나이고, 국내에서는 주로 소화장애, 염증성궤양 그리고 가려움증 등에 사용되어 왔다. 본 연구에서는 무화과 잎을 메탄올로 추출한 후 임상진료실에서 분리된 메티실린 내성 황색포도상구균(MRSA)에 대한 항균활성을 보았다. 그 결과 분리된 MRSA 1-20에서 최소억제농도 (MIC)는 2.5 mg/mL에서 20 mg/mL 농도로 측정되었으며, 최소살균농도(MBC)는 5 mg/mL에서 20 mg/mL 농도로 관찰되었다. Oxacillin이나 ampicillin과 병용투여 시 4-8배 이상의 MIC/MBC농도가 감소되었으며, FICI 값도 0.0375-0.5이하로 병용효과를 나타내었다. 더불어 메탄올추출물 단독 사용시 보다 항생제와 병용투여 시 빠른 사멸효과를 보였다. 결론적으로 무화과 잎이 메티실린 내성 황색포도상구균에 항균활성을 나타냄을 확인하였으며, 메티실린 내성 황색포도상구균 감염에 천연 치료제로서의 가능성을 확인하였다.

Keywords

References

  1. Aires de Sousa, M. and H. de Lencastre. 2004. Bridges from hospitals to the laboratory: genetic portraits of methicillinresistant Staphylococcus aureus clones. FEMS. Immunol. Med. Microbiol. 40: 101-111. https://doi.org/10.1016/S0928-8244(03)00370-5
  2. Aqil, F., I. Ahmad, and M. Owais. 2006. Evaluation of antimethicillin- resistant Staphylococcus aureus (MRSA) activity and synergy of some bioactive plant extracts. Biotechnol. J. 1: 1093-1102. https://doi.org/10.1002/biot.200600130
  3. Canal, J. R., M. D. Torres, A. Romero, and C. A. Perez. 2000. Chloroform extract obtained from a decoction of Ficus carica leaves improves the cholesterolaemic status of rats with streptozotocin-induced diabetes. Acta Physiologica. Hungarica 87: 71-76. https://doi.org/10.1556/APhysiol.87.2000.1.8
  4. Cha, J. D. 2009. Synergistic effect in combination of dansam (Salvia miltiorrhiza) extracts with antibiotics against methicillin-resistant Staphylococcus aureus. Food Sci. Biotechnol. 18: 1263-1272.
  5. Cha, J. D., S. E. Moon, J. Y. Kim, E. K. Jung, and Y. S. Lee. 2009. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillinresistant Staphylococcus aureus. Phytother. Res. 23: 1326-1331. https://doi.org/10.1002/ptr.2540
  6. Climo, M. W., R. L. Patron, and G. L. Archer. 1999. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob. Agents Chemother. 43: 1747-1753.
  7. Ephraim, P. L., M. P. Helena, D. P. Alison, and A. N. Robert. 2008. Ficus spp. (fig): Ethnobotany and potential as anticancer and anti-inflammatory agents. J. Ethnopharmacol. 119: 195-213. https://doi.org/10.1016/j.jep.2008.06.025
  8. Gilani, A. H., M. H. Mehmood, K. H. Janbaz, A. U. Khan, and S. A. Saeed. 2008. Ethnopharmacological studies on antispasmodic and antiplatelet activities of Ficus carica. J. Ethnopharmacol. 119: 1-5. https://doi.org/10.1016/j.jep.2008.05.040
  9. Isnansetyo, A. and Y. Kamei. 2003. Pseudoalteromonas phenolica sp. nov., a novel marine bacterium that produces phenolic anti-methicillin-resistant Staphylococcus aureus substances. Int. J. Syst. Evol. Microbiol. 53: 583-588. https://doi.org/10.1099/ijs.0.02431-0
  10. Jeong, M. R., H. Y. Kim, and J. D. Cha. 2009. Antimicrobial activity of methanol extract from Ficus carica leaves againstoral bacteria. J. Bacteriol. Virol. 39: 97-102. https://doi.org/10.4167/jbv.2009.39.2.97
  11. Jorgensen, M., R. Givney, M. Pegler, A. Vickery, and G. Funnell. 1996. Typing multidrug-resistant Staphylococcus aureus: conflicting epidemiological data produced by genotypic and phenotypic methods clarified by phylogenetic analysis. J. Clin. Microbiol. 34: 398-403.
  12. Kim, K. J., H. H. Yu, J. D. Cha, S. J. Seo, N. Y. Choi, and Y. O. You. 2005. Antibacterial Activity of Curcuma longa L. against Methicillin-resistant Staphylococcus aureus. Phytother. Res. 19: 599-604. https://doi.org/10.1002/ptr.1660
  13. Liu, I. X., D. G. Durham, and R. M. Richards. 2000. Baicalin synergy with beta-lactam antibiotics against methicillinresistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus. J. Pharm. Pharmacol. 52: 361-366. https://doi.org/10.1211/0022357001773922
  14. McGovern, T. W. 2002. The fig-Ficus carica L. Cutis. 69: 339-340.
  15. Miller, R. A., G. R. Humphrey, D. R. Lieberman, S. S. Ceglia, D. F. Kennedy, E. F. Grabowski, and P. J. Reider. 2000. A practical and efficient preparation of the releasable naphthosultam side chain of a novel anti-MRSA carbapenem. J. Org. Chem. 65: 1399-1406. https://doi.org/10.1021/jo991490k
  16. O'Connell, N. H., H. Humphreys, C. Pidgeon, and E. G. Smyth. 2003. Absence of risk factors for community MRSA. Clin. Microbiol. Infect. 9: 578-579. https://doi.org/10.1046/j.1469-0691.2003.00684.x
  17. Perez, C., J. R. Canal, J. E. Campillo, A. Romero, and M. D. Torres. 1999. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phytother. Res. 13: 188-191. https://doi.org/10.1002/(SICI)1099-1573(199905)13:3<188::AID-PTR411>3.0.CO;2-P
  18. Perez, C., J. R. Canal, and M. D. Torres. 2003. Experimental diabetes treated with Ficus carica extract: effect on oxidative stress parameters. Acta Diabetol. 40: 3-8. https://doi.org/10.1007/s005920300001
  19. Rubnov, S., Y. Kashman, R. Rabinowitz, M. Schlesinger, R. Mechoulam. 2001. Suppressors of cancer cell proliferation from fig (Ficus carica) resin: isolation and structure elucidation. J. Nat. Prod. 64: 993-996. https://doi.org/10.1021/np000592z
  20. Ryu, S. R., H. Cho, J. S. Jung, and S. T. Jung. 1998. The study on the separation and antitumor activity as new substances in fig. J. Applied Chem. 2: 961-964.
  21. Solomon, A., S. Golubowicz, Z. Yablowicz, S. Grossman, M. Bergman, H. E. Gottlieb, A. Altman, Z. Kerem, and M. A. Flaishman. 2006. Antioxidant activities and anthocyanin content of fresh fruits of common fig (Ficus carica L.). J. Agric. Food Chem. 20: 7717-7723.
  22. Teixeira, D. M., R. F. Patão, A. V. Coelho, and C. T. da Costa. 2006. Comparison between sample disruption methods and solid-liquid extraction (SLE) to extract phenolic compounds from F. carica leaves. J. Chromatogr. 1103: 22-28. https://doi.org/10.1016/j.chroma.2005.11.047
  23. Vaya, J. and S. Mahmood. 2006. Flavonoid content in leaf extracts of the fig (Ficus carica L.), carob (Ceratonia siliqua L.) and pistachio (Pistacia lentiscus L.). Biofactors 28: 169-175. https://doi.org/10.1002/biof.5520280303
  24. Wang, G., H. Wang, Y. Song, C. Jia, Z. Wang, and H. Xu. 2004. Studies on anti-HSV effect of Ficus carica leaves. Zhong Yao Cai 27: 754-756.
  25. Watson, J., R. Givney, M. Beard-Pegler, B. Rose, J. Merlino, A. Vickery, T. Gottlieb, R. Bradbury, and C. Harbour. 2003. Comparative analysis of multidrug-resistant, non-multidrugresistant, and archaic methicillin-resistant Staphylococcus aureus isolates from Central Sydney, Australia. J. Clin. Microbiol. 41: 867-872. https://doi.org/10.1128/JCM.41.2.867-872.2003